Source: Shutterstock/Lightspring

Nosocomial infections

Global-PPS: Hospital antibiotic resistance study tops 200k

BioMérieux and the Laboratory of Medical Microbiology at the University of Antwerp announced at ECCMID (European Congress of Clinical Microbiology & Infectious Diseases) the 2018 results of the Global Point Prevalence Survey (GLOBAL-PPS), a study of antibiotic use and antimicrobial resistance (AMR) in hospitals around the world. Since its launch in 2015, this survey has been conducted in nearly 800 hospital centers, in 80 countries and has collected data from over 200,000 hospitalized patients.

The GLOBAL-PPS is a survey of unprecedented scope that is repeated each year, gathering vital information on antibiotic prescribing and bacterial resistance to these treatments. It enables the participating hospitals to evolve in their antibiotic prescribing practices and implement actionable plans to encourage appropriate use of antibiotics as a means of combatting AMR. Through the quality of the collected data, it is possible to compare findings within a single center and among different centers, leading to the development of improvement plans at the hospital level or even at the national level.

Recommended article

Photo

Hospital hygiene

Nosocomial infections: a positive trend, but...

Hospital hygiene and how Germany compares in a European survey is somewhat divisive. Some believe Germany does well, whilst others emphasise the need to improve and for a stronger alignment with countries such as the Netherlands. As hygiene specialist Professor Petra Gastmeier, at the Institute of Hygiene and Environmental Medicine in Charité University Medical Centre Berlin, pointed out:…

In 2018, bioMérieux and the University of Antwerp awarded GLOBAL-PPS scholarships to three healthcare professionals from the Philippines, Brazil and Egypt. These scholarship recipients recently spent three weeks at the University of Antwerp, following an Antimicrobial Stewardship-focused training course and working closely with the GLOBAL-PPS organizers.

Antibiotic guidelines were still missing in many hospitals in Low and Middle Income Countries (LMIC), and, if available, compliance was unsatisfactory

Herman Goossens

“We were surprised of the continued widespread use of mainly broad-spectrum antibiotics in the 2018 GLOBAL-PPS, that were mainly prescribed for empirical treatment, illustrating the lack of diagnostics to document infections. Antibiotic guidelines were still missing in many hospitals in Low and Middle Income Countries (LMIC), and, if available, compliance was unsatisfactory. Another striking result was duration of peri-operative antibiotic prophylaxis: more than one day in about 80% of surgical patients in LMIC. Clearly, there is a need for training, and we will develop a dedicated e-learning course in 2019, enabling stewardship activities based on the GLOBAL-PPS results”, says Professor Herman Goossens, leader of the GLOBAL-PPS project. 

“We are very proud of supporting the GLOBAL-PPS from its early start because it provides hospitals around the world with information on antibiotic consumption and resistance rates. The data collected by the GLOBAL-PPS are pivotal to implement concrete and effective actions to reduce inappropriate use of antibiotics as a means to curb bacterial resistance”, says Mark Miller, Executive Vice President, Chief Medical Officer of bioMérieux.

The GLOBAL-PPS has been the subject of several major publications, including a paper in The Lancet Global Health, co-authored by the coordinating team of the University of Antwerp, Prof. Herman Goossens and Dr. Ann Versporten, GLOBAL-PPS participants and bioMérieux’s medical experts. Furthermore, the survey is now recognized by major international organizations (WHO, Doctors Without Borders, CDDEP, IDSA, BSAC...). In 2019, ten posters and two oral presentations about the GLOBAL-PPS were presented by participating hospitals at the ECCMID congress. In 2019, the GLOBAL-PPS will be repeated for the 5th consecutive year. It will include a new module on healthcare-associated infections (HAIs). This new module is an additional helpful tool to support hospitals in deploying their action plans to improve the appropriate use of antibiotics.


Source: bioMérieux

16.04.2019

Read all latest stories

Related articles

Photo

Alarming results

Antibiotic resistance spreads faster than previously thought

By studying fish raised in aquaculture, researchers from the Helmholtz Zentrum München, the University of Copenhagen and the University of Campinas in Brazil have shed new light on the mechanisms by…

Photo

DRUG resistance III

Antibiotic Armageddon in Europe by 2025

A group of leading scientists has warned that Britain and Europe collectively could face more than a million deaths in an impending "Antibiotic Armageddon” unless more is spent on developing…

Photo

Peering into the abyss

In May, the World Health Organisation (WHO) warned that bacterial infections might lead to an increasing number of deaths because new resistance mechanisms threaten our ability to treat common…

Related products

Atlas Genetics - Atlas Genetics io system

Infectious diseases testing

Atlas Genetics - Atlas Genetics io system

Atlas Genetics Ltd
Siemens Healthineers – Versant HCV Genotype 2.0 Assay (LiPA)

Infectious Disease/Hepatitis

Siemens Healthineers – Versant HCV Genotype 2.0 Assay (LiPA)

Siemens Healthineers